Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis.

Literature DB >> 22096070

Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis.

Christel Faes¹, Geert Molenberghs, Niel Hens, Arno Muller, Herman Goossens, Samuel Coenen.

Abstract

In this tutorial, statistical methods for studying outpatient use of antibiotics in Europe are described, using data provided by IMS Health. The methods are applied to two related research questions, namely the assessment of changes in the relative volume of use of different antibiotic subclasses over time and changes in the absolute volume of antibiotic use.

Entities: Species

Mesh：

Substances：

Year: 2011 PMID： 22096070 DOI： 10.1093/jac/dkr461

Source DB: PubMed Journal: J Antimicrob Chemother ISSN： 0305-7453 Impact factor: 5.790

Keyword Cloud
Cited

11 in total

1. Temporal changes in the proportion of Salmonella outbreaks associated with 12 food commodity groups in the United States.

Authors: Michael S Williams; Eric D Ebel
Journal: Epidemiol Infect Date: 2022-06-15 Impact factor: 4.434

2. Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease.

Authors: Fang Chen; Wenqing Su; Shawn H Becker; Mike Payne; Cynthia M Castro Sweet; Anne L Peters; Timothy M Dall
Journal: PLoS One Date: 2016-10-05 Impact factor: 3.240

3. The role of lifestyle and non-modifiable risk factors in the development of metabolic disturbances from childhood to adolescence.

Authors: Claudia Börnhorst; Paola Russo; Toomas Veidebaum; Michael Tornaritis; Dénes Molnár; Lauren Lissner; Staffan Mårild; Stefaan De Henauw; Luis A Moreno; Anna Floegel; Wolfgang Ahrens; Maike Wolters
Journal: Int J Obes (Lond) Date: 2020-09-17 Impact factor: 5.095

4. Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997-2017.

Authors: Ann Versporten; Robin Bruyndonckx; Niels Adriaenssens; Niel Hens; Dominique L Monnet; Geert Molenberghs; Herman Goossens; Klaus Weist; Samuel Coenen
Journal: J Antimicrob Chemother Date: 2021-07-26 Impact factor: 5.790

5. Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017: data collection, management and analysis.

Authors: Robin Bruyndonckx; Niels Adriaenssens; Ann Versporten; Niel Hens; Dominique L Monnet; Geert Molenberghs; Herman Goossens; Klaus Weist; Samuel Coenen
Journal: J Antimicrob Chemother Date: 2021-07-26 Impact factor: 5.790

6. Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997-2017.

Authors: Niels Adriaenssens; Robin Bruyndonckx; Ann Versporten; Niel Hens; Dominique L Monnet; Geert Molenberghs; Herman Goossens; Klaus Weist; Samuel Coenen
Journal: J Antimicrob Chemother Date: 2021-07-26 Impact factor: 5.790

Analysing the composition of outpatient antibiotic use: a tutorial on compositional data analysis.

1. Temporal changes in the proportion of Salmonella outbreaks associated with 12 food commodity groups in the United States.

2. Clinical and Economic Impact of a Digital, Remotely-Delivered Intensive Behavioral Counseling Program on Medicare Beneficiaries at Risk for Diabetes and Cardiovascular Disease.

3. The role of lifestyle and non-modifiable risk factors in the development of metabolic disturbances from childhood to adolescence.

4. Consumption of tetracyclines, sulphonamides and trimethoprim, and other antibacterials in the community, European Union/European Economic Area, 1997-2017.

5. Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017: data collection, management and analysis.

6. Consumption of macrolides, lincosamides and streptogramins in the community, European Union/European Economic Area, 1997-2017.

7. Consumption of antibiotics in the community, European Union/European Economic Area, 1997-2017.

8. Consumption of cephalosporins in the community, European Union/European Economic Area, 1997-2017.

9. Consumption of quinolones in the community, European Union/European Economic Area, 1997-2017.

10. Consumption of penicillins in the community, European Union/European Economic Area, 1997-2017.